Skip to content

Impact of Insecticide Resistance on Vector Control

Impact of Insecticide Resistance in Anopheles Arabiensis on the Effectiveness of Malaria Vector Control in Sudan

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01713517
Enrollment
28000
Registered
2012-10-24
Start date
2011-04-30
Completion date
2014-10-31
Last updated
2012-10-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malaria, Falciparum

Keywords

Mosquito Control, Insecticide Resistance

Brief summary

The purpose of the study is to determine whether long lasting insecticidal nets and indoor residual insecticide spraying, alone or in combination, are effective for controlling insecticide resistant anopheles mosquitoes for malaria prevention.

Detailed description

The study will assess the impact that insecticide resistance has on the effectiveness of malaria vector control tools LLIN and IRS. This is done by a cluster randomised trials of universal coverage LLINs versus universal coverage LLINs in combination with IRS, with levels of baseline insecticide resistance in the main vector balanced between the two study arms. In each cluster resistance to the insecticide used on LLINs is monitored, and malaria incidence is estimated from cluster specific cohorts of children followed up over the duration of the study. Resistance impact will be assessed from the ratio of incidence rates in clusters with high compared to those with low resistance and from a continuous measure of resistance expressed as percentage loss of mosquito mortality when exposed to insecticide in standardised WHO tests. Resistance mechanisms will be studied in subsets of study clusters.

Interventions

OTHERIndoor residual insecticide spraying (IRS)

Application of insecticide to interior walls of domiciliary structures to kill malaria vector mosquitoes which rest on walls after taking human blood meal

DEVICELong Lasting Insecticidal Nets (LLIN)

Provision of LLIN to all community members in the clusters allocated to the study arm. LLIN protect individuals from bites by malaria vector mosquitoes by providing a physical barrier and insecticidal and repellent effect.

Sponsors

Federal Ministry of Health, Sudan
CollaboratorOTHER_GOV
World Health Organization
CollaboratorOTHER
Liverpool School of Tropical Medicine
CollaboratorOTHER
London School of Hygiene and Tropical Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
6 Months to 10 Years
Healthy volunteers
Yes

Inclusion criteria

* Children older than 6 months and younger than 10 years in approximately 100 randomly selected households in all 140 study clusters selected in the four study areas

Exclusion criteria

* Children living in households within 1 km from the edge of a neighbouring cluster (the buffer zone)

Design outcomes

Primary

MeasureTime frameDescription
Malaria Incidence3 yearsInfection with malarial parasites determined by rapid diagnostic tests/microscopy in cohort members who report or have fever (\>37.5C)

Secondary

MeasureTime frameDescription
Prevalence of P.falciparum Infection3 yearsInfection with plasmodial parasites (falciparum and/or vivax) in randomly selected members of the study cohort in each study cluster during the peak of the malaria transmission season by rapid diagnostic test
Entomological Innoculation rateAverage for months Sept, Oct, Nov for years 2011, 2012, 2013Anopheles arabiensis mosquitoes collected in sentinel clusters by light trap, window trap, clay pot and pyrethrum sheet collection and determination of sporozoite, human blood index, feeding and resting behaviour.
Frequency of insecticide resistance associated genotypes (kdr) in anopheles arabiensisYearly average 2011, 2012, 2013, 2014Molecular analysis of mosquito specimens caught in subset of clusters by pyrethrum spray collection.

Countries

Sudan

Contacts

Primary ContactHmooda T Kafy, MSc (London)
hmoodak@yahoo.com+249 123 399 994
Backup ContactBashir A Ismail, MSc (USM)
bashiradam69@yahoo.co.uk+249 912938842

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026